A detailed history of Alpha Dna Investment Management LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 15,103 shares of CDNA stock, worth $376,215. This represents 0.18% of its overall portfolio holdings.

Number of Shares
15,103
Holding current value
$376,215
% of portfolio
0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$14.41 - $33.99 $217,634 - $513,350
15,103 New
15,103 $471,000
Q2 2021

Aug 10, 2021

SELL
$63.02 - $95.11 $4,033 - $6,087
-64 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$57.62 - $95.6 $1,728 - $2,868
-30 Reduced 31.91%
64 $3,000
Q4 2020

Mar 24, 2021

BUY
$41.43 - $77.09 $1,698 - $3,160
41 Added 77.36%
94 $6,000
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $2,195 - $4,085
53 New
53 $3,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.33B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.